retatrutide discord and the Grey Market: Buyer Beware – Sarah Hormachea Retatrutide Before FDA Approval? Lilly

Our clinical mantra is cautious curiosity: we are curious enough to try new tools, but cautious enough to prioritize safety, transparency, and measurable goals

The study enrolled 307 adults with obesity or overweight and followed them for 64 weeks

Albiglutide was discontinued for low prescription rates rather than safety concerns [70, 71]

Reta Dosage: A Guide

The brand source materials state explicitly that "no data, photos, claims, or other information presented are derived from clinical trials or public studies and are representative of altRx patient experience only." In plain terms: the figures altRx publishes are self-reported customer data, not clinical trial outcomes, not peer-reviewed study results, and not guarantees of any specific outcome for any individual patient